BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lopes AJ, de Menezes SL, Dias CM, de Oliveira JF, Mainenti MR, Guimarães FS. Comparison between cardiopulmonary exercise testing parameters and computed tomography findings in patients with thoracic sarcoidosis. Lung 2011;189:425-31. [PMID: 21858420 DOI: 10.1007/s00408-011-9316-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Marcellis RG, Lenssen AF, de Vries J, Drent M. Reduced muscle strength, exercise intolerance and disabling symptoms in sarcoidosis: . Current Opinion in Pulmonary Medicine 2013;19:524-30. [DOI: 10.1097/mcp.0b013e328363f563] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
2 Baughman RP, Lower EE, Gibson K. Pulmonary manifestations of sarcoidosis. La Presse Médicale 2012;41:e289-302. [DOI: 10.1016/j.lpm.2012.03.019] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
3 Chopra A, Kalkanis A, Judson MA. Biomarkers in sarcoidosis. Expert Rev Clin Immunol 2016;12:1191-208. [PMID: 27253883 DOI: 10.1080/1744666X.2016.1196135] [Cited by in Crossref: 39] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
4 Patel DC, Budev M, Culver DA. Advanced (“End-Stage”) Pulmonary Sarcoidosis. In: Judson MA, editor. Pulmonary Sarcoidosis. New York: Springer; 2014. pp. 79-110. [DOI: 10.1007/978-1-4614-8927-6_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
5 Lopes A, Costa W, Thomaz Mafort T, de Sá Ferreira A, Silveira de Menezes S, Silva Guimarães F. Silicosis in sandblasters of shipyard versus silicosis in stone carvers in Brazil: A comparison of imaging findings, lung function variables and cardiopulmonary exercise testing parameters. Revista Portuguesa de Pneumologia (English Edition) 2012;18:260-6. [DOI: 10.1016/j.rppnen.2012.06.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Marcellis RGJ, Lenssen AF, de Vries GJ, Baughman RP, van der Grinten CP, Verschakelen JA, De Vries J, Drent M. Is There an Added Value of Cardiopulmonary Exercise Testing in Sarcoidosis Patients? Lung 2013;191:43-52. [DOI: 10.1007/s00408-012-9432-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
7 Patterson KC, Strek ME. Pulmonary fibrosis in sarcoidosis. Clinical features and outcomes. Ann Am Thorac Soc 2013;10:362-70. [PMID: 23952859 DOI: 10.1513/AnnalsATS.201303-069FR] [Cited by in Crossref: 65] [Cited by in F6Publishing: 28] [Article Influence: 8.1] [Reference Citation Analysis]
8 Jeong YJ, Lynch DA, Rho JY, Hamzeh NY, Suh YJ. Computed Tomographic Scoring Systems in Sarcoidosis: Comparison With Cardiopulmonary Exercise Testing Parameters. J Thorac Imaging 2016;31:104-10. [PMID: 26891073 DOI: 10.1097/RTI.0000000000000198] [Reference Citation Analysis]
9 Lopes A, Costa W, Thomaz Mafort T, de Sá Ferreira A, Silveira de Menezes S, Silva Guimarães F. Silicose em jateadores de areia de estaleiro versus silicose em escultores de pedra no Brasil: uma comparação dos achados de imagem, função pulmonar e teste de exercício cardiopulmonar. Revista Portuguesa de Pneumologia 2012;18:260-6. [DOI: 10.1016/j.rppneu.2012.04.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
10 Gerke AK, Judson MA, Cozier YC, Culver DA, Koth LL. Disease Burden and Variability in Sarcoidosis. Ann Am Thorac Soc 2017;14:S421-8. [PMID: 29087725 DOI: 10.1513/AnnalsATS.201707-564OT] [Cited by in Crossref: 52] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
11 Malur A, Mohan A, Barrington RA, Leffler N, Malur A, Muller-Borer B, Murray G, Kew K, Zhou C, Russell J, Jones JL, Wingard CJ, Barna BP, Thomassen MJ. Peroxisome Proliferator-activated Receptor-γ Deficiency Exacerbates Fibrotic Response to Mycobacteria Peptide in Murine Sarcoidosis Model. Am J Respir Cell Mol Biol 2019;61:198-208. [PMID: 30741559 DOI: 10.1165/rcmb.2018-0346OC] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]